Financial Conflicts of Interest are of Higher Ethical Priority than "Intellectual" Conflicts of Interest.

Bioethics Conflicts of interest Financial Interests Public health ethics

Journal

Journal of bioethical inquiry
ISSN: 1872-4353
Titre abrégé: J Bioeth Inq
Pays: Netherlands
ID NLM: 101250741

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 10 05 2019
accepted: 10 06 2020
pubmed: 2 7 2020
medline: 14 9 2021
entrez: 2 7 2020
Statut: ppublish

Résumé

The primary claim of this paper is that intellectual conflicts of interest (COIs) exist but are of lower ethical priority than COIs flowing from relationships between health professionals and commercial industry characterized by financial exchange. The paper begins by defining intellectual COIs and framing them in the context of scholarship on non-financial COIs. However, the paper explains that the crucial distinction is not between financial and non-financial COIs but is rather between motivations for bias that flow from relationships and those that do not. While commitments to particular ideas or perspectives can cause all manner of cognitive bias, that fact does not justify denying the enormous power that relationships featuring pecuniary gain have on professional behaviour in term of care, policy, or both. Sufficient reason exists to take both intellectual COIs and financial COIs seriously, but this paper demonstrates why the latter is of higher ethical priority. Multiple reasons will be provided, but the primary rationale grounding the claim is that intellectual COIs may provide reasons to suspect cognitive bias but they do not typically involve a loss of trust in a social role. The same cannot be said for COIs flowing from relationships between health professionals and commercial industries involving financial exchange. The paper then assumes arguendo that the primary rationale is mistaken and proceeds to show why the claims that intellectual COIs are more significant than relationship-based COIs are dubious on their own merits. The final section of the paper summarizes and concludes.

Identifiants

pubmed: 32607925
doi: 10.1007/s11673-020-09989-4
pii: 10.1007/s11673-020-09989-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-227

Commentaires et corrections

Type : CommentIn

Auteurs

Daniel S Goldberg (DS)

Core Faculty, Center for Bioethics and Humanities, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. daniel.goldberg@cuanschutz.edu.
Department of Family Medicine (CU School of Medicine), University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. daniel.goldberg@cuanschutz.edu.
Department of Epidemiology (CO School of Public Health), University of Colorado, Anschutz Medical Campus, Fulginiti Pavilion - Room 205, 13080 E. 19th Avenue, CB B137, Aurora, CO, 80045, USA. daniel.goldberg@cuanschutz.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH